Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meeting, 987 [2024-00162]

Download as PDF Federal Register / Vol. 89, No. 5 / Monday, January 8, 2024 / Notices increase in each of the rates in sections 1114, 1115(1), and 1162 of title 38, United States Code. VA is required to increase these benefit rates by the same percentage as increases in the benefit amounts payable under title II of the Social Security Act. The increased rates are required to be published in the Federal Register. The Social Security Administration has announced that there will be a 3.2% cost-of-living increase in Social Security benefits for 2024. Therefore, applying the same percentage, the following rates for VA’s compensation program became effective on December 1, 2023: Disability Compensation [38 U.S.C. 1114] $171.23 338.49 524.31 755.28 1,075.16 1,361.88 1,716.28 1,995.01 2,241.91 3,737.85 132.74 4,651.06 5,132.92 5,839.08 6,526.64 6,526.64 2,799.43; 4,170.59 4,183.85 4,170.59 Additional Compensation for Dependents [38 U.S.C. 1115(1)] 38 38 38 38 38 38 U.S.C. U.S.C. U.S.C. U.S.C. U.S.C. U.S.C. 1115(1)(A) 1115(1)(B) 1115(1)(C) 1115(1)(D) 1115(1)(E) 1115(1)(F) .............. .............. .............. .............. .............. .............. 208.40 361.02; 103.55 139.37; 103.55 167.26 399.54 334.49 Clothing Allowance [38 U.S.C. 1162] $999.51 per year. Signing Authority ddrumheller on DSK120RN23PROD with NOTICES1 Denis McDonough, Secretary of Veterans Affairs, approved and signed this document on January 2, 2024, and authorized the undersigned to sign and VerDate Sep<11>2014 16:46 Jan 05, 2024 Jkt 262001 Luvenia Potts, Regulation Development Coordinator, Office of Regulation Policy & Management, Office of the Secretary, Department of Veterans Affairs. [FR Doc. 2024–00160 Filed 1–5–24; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meeting Monthly rate Disability evaluation percentage: 10 ......................................... 20 ......................................... 30 ......................................... 40 ......................................... 50 ......................................... 60 ......................................... 70 ......................................... 80 ......................................... 90 ......................................... 100 ....................................... 38 U.S.C. 1114(k) through (t)): 38 U.S.C. 1114(k) ................ 38 U.S.C. 1114(l) ................. 38 U.S.C. 1114(m) .............. 38 U.S.C. 1114(n) ............... 38 U.S.C. 1114(o) ............... 38 U.S.C. 1114(p) ............... 38 U.S.C. 1114(r) ................ 38 U.S.C. 1114(s) ................ 38 U.S.C. 1114(t) ................ submit the document to the Office of the Federal Register for publication electronically as an official document of the Department of Veterans Affairs. The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. ch.10, that a meeting of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board will be held January 30, 2024, via Webex. The meeting will be held between 3 p.m. and 5 p.m. EDT. The meeting will be closed to the public from 3:30–5 p.m. EDT for the discussion, examination and reference to the research applications and scientific review. Discussions will involve reference to staff and consultant critiques of research proposals. Discussions will deal with scientific merit of each proposal and qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals. As provided by Public Law 92–463 subsection 10(d), as amended by Public Law 94–409, closing the committee meeting is in accordance with 5 U.S.C. 552b(c) (6) and (9)(B). The objective of the Board is to provide for the fair and equitable selection of the most meritorious PO 00000 Frm 00089 Fmt 4703 Sfmt 9990 987 research projects for support by VA research funds and to offer advice for research program officials on program priorities and policies. The ultimate objective of the Board is to ensure the high quality and mission relevance of VA’s legislatively mandated Biomedical Laboratory and Clinical Science Research and Development programs. Board members advise the Directors of the Biomedical Laboratory and Clinical Sciences Research Services and the Chief Research and Development Officer on the scientific and technical merit, the mission relevance, and the protection of human subjects of Biomedical Laboratory and Clinical Sciences Research and Development proposals. The Board does not consider grants, contracts, or other forms of extramural research. Members of the public may attend the open portion of the meeting. The time limited agenda does not enable public comments or presentations. To attend the open portion of the meeting (3–3:30 p.m. EDT), the public may join by dialing the phone number 1–404–397– 1596 and entering the meeting number (access code): 2763 451 0764. Written public comments must be sent to Michael R. Burgio, Ph.D., Designated Federal Officer, Office of Research and Development, Department of Veterans Affairs (14RD), 810 Vermont Avenue NW, Washington, DC 20420, or to Michael.Burgio@va.gov at least five days before the meeting via the email listed above. The written public comments will be shared with the board members. The public may not attend the closed portion of the meeting as disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals (Pub. L. 92–463 subsection 10(d), as amended by Pub. L. 94–409, closing the committee meeting is in accordance with title 5 U.S.C. 552b(c)(6) and (9)(B). Dated: January 3, 2024. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2024–00162 Filed 1–5–24; 8:45 am] BILLING CODE P E:\FR\FM\08JAN1.SGM 08JAN1

Agencies

[Federal Register Volume 89, Number 5 (Monday, January 8, 2024)]
[Notices]
[Page 987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00162]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board, Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. ch.10, that a meeting of the 
Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review Board 
will be held January 30, 2024, via Webex. The meeting will be held 
between 3 p.m. and 5 p.m. EDT. The meeting will be closed to the public 
from 3:30-5 p.m. EDT for the discussion, examination and reference to 
the research applications and scientific review. Discussions will 
involve reference to staff and consultant critiques of research 
proposals. Discussions will deal with scientific merit of each proposal 
and qualifications of personnel conducting the studies, the disclosure 
of which would constitute a clearly unwarranted invasion of personal 
privacy. Additionally, premature disclosure of research information 
could significantly obstruct implementation of proposed agency action 
regarding the research proposals. As provided by Public Law 92-463 
subsection 10(d), as amended by Public Law 94-409, closing the 
committee meeting is in accordance with 5 U.S.C. 552b(c) (6) and 
(9)(B).
    The objective of the Board is to provide for the fair and equitable 
selection of the most meritorious research projects for support by VA 
research funds and to offer advice for research program officials on 
program priorities and policies. The ultimate objective of the Board is 
to ensure the high quality and mission relevance of VA's legislatively 
mandated Biomedical Laboratory and Clinical Science Research and 
Development programs.
    Board members advise the Directors of the Biomedical Laboratory and 
Clinical Sciences Research Services and the Chief Research and 
Development Officer on the scientific and technical merit, the mission 
relevance, and the protection of human subjects of Biomedical 
Laboratory and Clinical Sciences Research and Development proposals. 
The Board does not consider grants, contracts, or other forms of 
extramural research.
    Members of the public may attend the open portion of the meeting. 
The time limited agenda does not enable public comments or 
presentations. To attend the open portion of the meeting (3-3:30 p.m. 
EDT), the public may join by dialing the phone number 1-404-397-1596 
and entering the meeting number (access code): 2763 451 0764.
    Written public comments must be sent to Michael R. Burgio, Ph.D., 
Designated Federal Officer, Office of Research and Development, 
Department of Veterans Affairs (14RD), 810 Vermont Avenue NW, 
Washington, DC 20420, or to [email protected] at least five days 
before the meeting via the email listed above. The written public 
comments will be shared with the board members. The public may not 
attend the closed portion of the meeting as disclosure of research 
information could significantly obstruct implementation of proposed 
agency action regarding the research proposals (Pub. L. 92-463 
subsection 10(d), as amended by Pub. L. 94-409, closing the committee 
meeting is in accordance with title 5 U.S.C. 552b(c)(6) and (9)(B).

    Dated: January 3, 2024.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-00162 Filed 1-5-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.